68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®). (Q53283178)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Yodphat Krausz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nanette Freedman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Rina Rubinstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Efraim Lavie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Marina Orevi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sagi Tshori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Asher Salmon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Roland Chisin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Eyal Mishani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

David J Gross

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

Molecular Imaging and Biology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

583-593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11307-010-0374-1

8 February 2020

exact match

0 references

cites work

Gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0374-1

Peptide receptor imaging and therapy

21 January 2018

1 reference

12 December 2020

68Ga-DOTATATE PET in neuroectodermal tumours: first experience

1 reference

12 December 2020

Processing of generator-produced 68Ga for medical application.

1 reference

12 December 2020

Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake

1 reference

12 December 2020

10.1007/S11307-010-0374-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20652423%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference